Article Details
Retrieved on: 2021-07-01 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche is set to seek early FDA approval for its Alzheimer's disease candidate gantenerumab, joining Eli Lilly in the race through the door opened by ...
Article found on: www.fiercebiotech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here